Cargando…
Deleted in breast cancer 1 as a potential prognostic biomarker in human cancers: a pooled analysis of 2,254 patients
BACKGROUND: Deleted in breast cancer 1 (DBC1) is believed to be involved in human cancers. However, it is still uncertain whether DBC1 expression can be regarded as a prognostic factor in patients with various cancers. This meta-analysis aimed to evaluate the relationship between high levels of DBC1...
Autores principales: | Liu, Gang, Wu, Qiaosheng, Wang, Yili, Xiong, Qiuyun, Fu, Feiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390861/ https://www.ncbi.nlm.nih.gov/pubmed/30863120 http://dx.doi.org/10.2147/OTT.S189618 |
Ejemplares similares
-
2254: iobio: From academic project to commercial enterprise
por: Ward, Alistair N., et al.
Publicado: (2018) -
PReS-FINAL-2254: Is it systemic JIA or post infectious illness?
por: Guddeti, P, et al.
Publicado: (2013) -
PB2254: TREATMENT OUTCOME AND PROGNOSTIC FACTORS IN CHILDREN AND ADOLESCENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA
por: Ali, Nesreen, et al.
Publicado: (2023) -
Draft Genome Sequence of Pseudomonas syringae pv. persicae NCPPB 2254
por: Zhao, Wenjun, et al.
Publicado: (2015) -
2254. Multicenter Evaluation of Ceftazidime–Avibactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)